Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08MTG
|
||||
Former ID |
DIB003924
|
||||
Drug Name |
Abafungin
|
||||
Synonyms |
Abasol; W-634; YP-006; YP-007; Abafungin (gel formulation), York Pharma; Abafungin (cream, dermatomycosis), York Pharma; Abafungin (gel formulation, onychomycosis), York Pharma; Abafungin (pessary, vaginal candidiasis), York Pharma
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Fungal infections [ICD9: 110-118; ICD10:B35-B49] | Discontinued in Phase 3 | [548190] | ||
Company |
York Pharma
|
||||
Structure |
Download2D MOL |
||||
Formula |
C21H22N4OS
|
||||
Canonical SMILES |
c1(nc(c2c(Oc3c(cc(cc3)C)C)cccc2)cs1)NC1=NCCCN1
|
||||
CAS Number |
CAS 129639-79-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fungal Cytochrome P450 51 | Target Info | Inhibitor | [527740] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.